CRISPR gene editing fervor pushes another biotech to go public https://t.co/MzGJUaoaZ6?
— The Propell Group (@ThePropellGroup) September 16, 2016
#healthtech
CRISPR gene editing fervor pushes another biotech to go public https://t.co/MzGJUaoaZ6?
— The Propell Group (@ThePropellGroup) September 16, 2016
#healthtech